Although the results of this study were consistent with those of KEYNOTE-224, overall survival and progression-free survival did not reach statistical significance in this study ( 113 ).
← all excerpts
Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma.
1
—
—